Artiva Biotherapeutics Inc (ARTV)
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
$4.13-2.13%
Close 2026-11-05 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-11-04
QuarterlyIQ Insights · ARTV
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenues | — | — | 0.3 | 33.5 | — |
| Total Revenues | — | — | 0.3 | 33.5 | — |
| Operating Expenses & Income | |||||
| R&D Expenses | 75.9 | 69.5 | 50.3 | 50.3 | — |
| Operating Income | (96.1) | (89.8) | (67.3) | (30.7) | — |
| Earnings from Continuing Operations | |||||
| Other Non-Operating Income / Expenses | 5.3 | 5.9 | 1.9 | 2.0 | — |
| Asset Writedown | — | — | — | 0.0 | — |
| EBT, Incl. Unusual Items | — | — | (65.4) | (28.6) | — |
| Income Tax Expense | — | — | — | 0.1 | — |
| Net Income | |||||
| Net Income | (90.8) | (83.9) | (65.4) | (28.7) | — |
| Per Share | |||||
| Basic EPS | (2.30) | (3.43) | (5.81) | (35.78) | — |
| Diluted EPS | (2.30) | (3.43) | (5.81) | (35.78) | — |
| Basic Weighted Avg Shares | 39.4 | 24.4 | 11.3 | 0.8 | — |
| Diluted Weighted Avg Shares | 39.4 | 24.4 | 11.3 | 0.8 | — |
| Supplemental | |||||
| EBITDA | — | (87.2) | (64.9) | (28.4) | — |
| EBIT | (96.1) | (89.8) | (67.3) | (30.7) | — |
| Effective Tax Rate | — | — | — | -0.3% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.